Testing venous carbohydrate‐deficient transferrin or capillary phosphatidylethanol with concurrent ethyl glucuronide and ethyl palmitate hair tests to assess historical and recent alcohol use

2020 ◽  
Author(s):  
Lolita Tsanaclis ◽  
Marie Davies ◽  
Sian Bevan ◽  
James Nutt ◽  
Kim Bagley ◽  
...  

2013 ◽  
Vol 49 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Juha Rainio ◽  
Sanna Ahola ◽  
Päivikki Kangastupa ◽  
Johanna Kultti ◽  
Heidi Tuomi ◽  
...  


2011 ◽  
Vol 39 (1) ◽  
pp. 365-369 ◽  
Author(s):  
Napoleon Waszkiewicz ◽  
Sławomir Dariusz Szajda ◽  
Alina Kępka ◽  
Agata Szulc ◽  
Krzysztof Zwierz

Up to 30% of all hospital admissions and health-care costs may be attributable to alcohol abuse. Ethanol, its oxidative metabolites, acetaldehyde and ROS (reactive oxygen species), non-oxidative metabolites of alcohol [e.g. FAEEs (fatty acid ethyl esters)] and the ethanol–water competition mechanism are all involved in the deregulation of glycoconjugate (glycoprotein, glycolipid and proteoglycan) metabolic processes including biosynthesis, modification, transport, secretion, elimination and catabolism. An increasing number of new alcohol biomarkers that are the result of alcohol-induced glycoconjugate metabolic errors have appeared in the literature. Glycoconjugate-related alcohol markers are involved in, or are a product of, altered glycoconjugate metabolism, e.g. CDT (carbohydrate-deficient transferrin), SA (sialic acid), plasma SIJ (SA index of apolipoprotein J), CETP (cholesteryl ester transfer protein), β-HEX (β-hexosaminidase), dolichol, EtG (ethyl glucuronide) etc. Laboratory tests based on changes in glycoconjugate metabolism are useful in settings where the co-operativeness of the patient is impaired (e.g. driving while intoxicated) or when a history of alcohol use is not available (e.g. after trauma). In clinical practice, glycoconjugate markers of alcohol use/abuse let us distinguish alcoholic from non-alcoholic tissue damage, having important implications for the treatment and management of diseases.



2014 ◽  
Vol 60 (10) ◽  
pp. 1347-1348 ◽  
Author(s):  
Hugo Neels ◽  
Michel Yegles ◽  
Geert Dom ◽  
Adrian Covaci ◽  
Cleo L Crunelle


2014 ◽  
Vol 23 (5) ◽  
pp. 334-346 ◽  
Author(s):  
Keith A. King ◽  
Rebecca A. Vidourek ◽  
Mallory K. Hill


2017 ◽  
Vol 26 (7) ◽  
pp. 673-675 ◽  
Author(s):  
Michael Gerard McDonell ◽  
Emily Leickly ◽  
Sterling McPherson ◽  
Jordan Skalisky ◽  
Katherine Hirchak ◽  
...  


2007 ◽  
Vol 172 (1) ◽  
pp. 23-27 ◽  
Author(s):  
Lucia Politi ◽  
Alessandra Zucchella ◽  
Luca Morini ◽  
Cristiana Stramesi ◽  
Aldo Polettini


2017 ◽  
Vol 66 (1) ◽  
pp. S349
Author(s):  
J. Verbeek ◽  
C.L. Crunelle ◽  
P. Michielsen ◽  
M. De Doncker ◽  
T. Roskams ◽  
...  


Author(s):  
Isabella Mercurio ◽  
Pamela Politi ◽  
Eleonora Mezzetti ◽  
Fausto Agostinelli ◽  
Gianmarco Troiano ◽  
...  

Abstract Aim To clarify the role of the ethanol metabolites, ethyl glucuronide (EtG) and ethyl sulfate (EtS), in monitoring alcohol consumption. Method We recruited 7 female and 17 male volunteers who were instructed to consume a quantity of beer (containing 48 gm ethanol) with food in one session. We examined urinary excretion of EtG and EtS over time and looked for correlations between the concentrations of the metabolites EtG and EtS. Results EtG concentrations in urine varied between 0.026 and 430.372 μg/ml with average values between 11.85 μg/ml (SD 19.75), 30 min after alcohol intake, and 100.39 μg/ml (SD 101.34), 4.5 h after alcohol intake. EtS urinary concentration ranged from 0.006 to 101.432 μg/ml with average values between 4.77 μg/ml (SD 5.42), 30 min after alcohol intake, and 30.14 μg/ml (SD 27.20), 4.5 h after alcohol intake. Spearman’s test showed that urinary EtG and EtS correlated significantly at several time points. Conclusion The great interindividual variability in their excretion suggests caution in the use of urinary measurement of these metabolites in forensic investigations.



2000 ◽  
Vol 46 (12) ◽  
pp. 1894-1902 ◽  
Author(s):  
Kay Scouller ◽  
Katherine M Conigrave ◽  
Petra Macaskill ◽  
Les Irwig ◽  
John B Whitfield

Abstract Background: Carbohydrate-deficient transferrin (CDT) has been used as a test for excessive alcohol consumption in research, clinical, and medico-legal settings, but there remain conflicting data on its accuracy, with sensitivities ranging from <20% to 100%. We examined evidence of its benefit over a conventional and less expensive test, γ-glutamyltransferase (GGT), and compared the accuracy of different CDT assay methods. Methods: We performed a systematic review using summary ROC analysis of 110 studies prior to June 1998 on the use of CDT in the detection of alcohol dependence or hazardous/harmful alcohol use. Results: We identified several potential sources of bias in studies. In studies examining CDT and GGT in the same subjects, subject characteristics were less likely to influence the comparison. In such paired studies, the original Pharmacia CDT assay was significantly more accurate than GGT, but the modified CDTect assay did not perform as well as the original and was not significantly better than GGT. The accuracy of the AXIS %CDT assay was statistically indistinguishable from modified CDTect. Several CDT assay methods appeared promising, in particular, liquid chromatography (chromatofocusing, HPLC, fast protein liquid chromatography) and isoelectric focusing, but there were insufficient paired studies from which to draw firm conclusions. Conclusions: In studies published before June 1998, the results obtained with commercially available CDT assays were not significantly better than GGT as markers of excessive alcohol use in paired studies. Further high-quality studies comparing CDTect (modified) and other CDT assays with GGT in the same subjects are needed.





Sign in / Sign up

Export Citation Format

Share Document